Neurogene Inc. (NGNE) on Tuesday reported a loss of $34.5 million in its second quarter. The New York-based company said it had a loss of $1.53 per share.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.40 per share.
Original reporting: Alexandria, VA News – WTOP News — read the source article.